tetano
Editor, Senior Moderator
Ann Med Surg (Lond)
. 2022 May;77:103706.
doi: 10.1016/j.amsu.2022.103706. Epub 2022 May 2.
Acute hepatitis with portal and mesenteric vein thrombosis revealing SARS-CoV-2 infection: Case report and literature review
Abdelhakim Harouachi[SUP] 1 2 [/SUP], Tariq Bouhout[SUP] 1 2 [/SUP], Hanane Hadj Kacem[SUP] 2 3 [/SUP], Badr Serji[SUP] 1 2 [/SUP], Hayat Berkhli[SUP] 2 4 [/SUP], Hamid Madani[SUP] 2 4 [/SUP], Tijani El Harroudi[SUP] 1 2 [/SUP]
Affiliations
Abstract
Novel coronavirus disease 2019 (COVID-19) is a single-stranded RNA virus identified for the first time in Wuhan, China, and it unfurls quickly worldwide. The corona virus 2019 is a systemic disease which develops a prothrombotic environment, and has an extensive spectrum of clinical presentations in the gastrointestinal and hepatobiliary systems. Ischemic hepatitis (hypoxic hepatitis) is one potential mechanism behind lessened perfusion of the liver. The portal and mesenteric vein thrombosis are extremely rare complications and unusual main manifestations of COVID-19. We report the case of a patient presented acute hepatitis with portal and mesenteric vein thrombosis revealing a SARS-CoV-2 infection. In addition, we discuss the most characteristic elements of the Impact of COVID-19 on liver Injury, and the mechanisms of this damage and the formation of thrombus in portal and mesenteric vein.
Keywords: Acute hepatitis; COVID-19; Portal and mesenteric vein thrombosis.
. 2022 May;77:103706.
doi: 10.1016/j.amsu.2022.103706. Epub 2022 May 2.
Acute hepatitis with portal and mesenteric vein thrombosis revealing SARS-CoV-2 infection: Case report and literature review
Abdelhakim Harouachi[SUP] 1 2 [/SUP], Tariq Bouhout[SUP] 1 2 [/SUP], Hanane Hadj Kacem[SUP] 2 3 [/SUP], Badr Serji[SUP] 1 2 [/SUP], Hayat Berkhli[SUP] 2 4 [/SUP], Hamid Madani[SUP] 2 4 [/SUP], Tijani El Harroudi[SUP] 1 2 [/SUP]
Affiliations
- PMID: 35531429
- PMCID: PMC9060732
- DOI: 10.1016/j.amsu.2022.103706
Abstract
Novel coronavirus disease 2019 (COVID-19) is a single-stranded RNA virus identified for the first time in Wuhan, China, and it unfurls quickly worldwide. The corona virus 2019 is a systemic disease which develops a prothrombotic environment, and has an extensive spectrum of clinical presentations in the gastrointestinal and hepatobiliary systems. Ischemic hepatitis (hypoxic hepatitis) is one potential mechanism behind lessened perfusion of the liver. The portal and mesenteric vein thrombosis are extremely rare complications and unusual main manifestations of COVID-19. We report the case of a patient presented acute hepatitis with portal and mesenteric vein thrombosis revealing a SARS-CoV-2 infection. In addition, we discuss the most characteristic elements of the Impact of COVID-19 on liver Injury, and the mechanisms of this damage and the formation of thrombus in portal and mesenteric vein.
Keywords: Acute hepatitis; COVID-19; Portal and mesenteric vein thrombosis.